Özlem Türeci

Person

Mainz, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for prediction of therapeutic efficacy of...
- Patent number 12,188,097
- Issue date Jan 7, 2025
- Astellas Pharma Inc.
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coronavirus vaccine
- Patent number 12,133,899
- Issue date Nov 5, 2024
- BIONTECH SE
- Ugur Sahin
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Combination therapy involving antibodies against Claudin 18.2 for t...
- Patent number 12,059,464
- Issue date Aug 13, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against claudin 18.2 useful in cancer diagnosis
- Patent number 11,976,130
- Issue date May 7, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Coronavirus vaccine
- Patent number 11,925,694
- Issue date Mar 12, 2024
- BIONTECH SE
- Ugur Sahin
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Antibodies useful in cancer diagnosis
- Patent number 11,919,951
- Issue date Mar 5, 2024
- Astellas Pharma Inc.
- Rita Mitnacht-Kraus
- G01 - MEASURING TESTING
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 11,858,988
- Issue date Jan 2, 2024
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 11,859,008
- Issue date Jan 2, 2024
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy involving antibodies against claudin 18.2 for t...
- Patent number 11,826,402
- Issue date Nov 28, 2023
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diagnosis and therapy of cancer involving cancer stem cells
- Patent number 11,795,218
- Issue date Oct 24, 2023
- BioNTech AG
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Grant
Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2...
- Patent number 11,787,862
- Issue date Oct 17, 2023
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Monoclonal antibodies against Claudin-18 for treatment of cancer
- Patent number 11,739,139
- Issue date Aug 29, 2023
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for prediction of therapeutic efficacy of...
- Patent number 11,732,308
- Issue date Aug 22, 2023
- Astellas Pharma Inc.
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Claudin-18.2-specific immunoreceptors and T cell epitopes
- Patent number 11,713,346
- Issue date Aug 1, 2023
- BioNtech Cell & Gene Therapies GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coronavirus vaccine
- Patent number 11,547,673
- Issue date Jan 10, 2023
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Drug conjugates comprising antibodies against claudin 18.2
- Patent number 11,541,127
- Issue date Jan 3, 2023
- Astellas Pharma, Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for diagnosis and treatment of cancer
- Patent number 11,473,085
- Issue date Oct 18, 2022
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapy involving antibodies against Claudin 18.2 for treatment of...
- Patent number 11,395,852
- Issue date Jul 26, 2022
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Claudin-6-specific immunoreceptors and t cell epitopes
- Patent number 11,345,731
- Issue date May 31, 2022
- BioNtech Cell & Gene Therapies GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen-specific T cell receptors and T cell epitopes
- Patent number 11,311,611
- Issue date Apr 26, 2022
- BioNtech Cell & Gene Therapies GmbH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant vaccines and use thereof
- Patent number 11,298,426
- Issue date Apr 12, 2022
- BIONTECH SE
- Ozlem Tureci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies useful in cancer diagnosis
- Patent number 11,279,757
- Issue date Mar 22, 2022
- Astellas Pharma Inc.
- Rita Mitnacht-Kraus
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy involving antibodies against claudin 18.2 for t...
- Patent number 10,946,069
- Issue date Mar 16, 2021
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for prediction of therapeutic efficacy of...
- Patent number 10,927,413
- Issue date Feb 23, 2021
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 10,919,974
- Issue date Feb 16, 2021
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer therapy using CLDN6 target-directed antibodies in vivo
- Patent number 10,844,133
- Issue date Nov 24, 2020
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy involving antibodies against Claudin 18.2 for t...
- Patent number 10,813,996
- Issue date Oct 27, 2020
- Astellas Pharma Inc.
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 10,745,477
- Issue date Aug 18, 2020
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies against claudin-18 for treatment of cancer
- Patent number 10,738,108
- Issue date Aug 11, 2020
- Astellas Pharma Inc.
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Identification of surface associated antigen FLJ31461 for tumor dia...
- Patent number 10,724,103
- Issue date Jul 28, 2020
- Ozlem Tureci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELLS FOR THE TREATMENT OF CLDN6...
- Publication number 20250025505
- Publication date Jan 23, 2025
- BIONTECH SE
- Ugur SAHIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...
- Publication number 20240335533
- Publication date Oct 10, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS
- Publication number 20240309108
- Publication date Sep 19, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Application
Agents for Treatment of Claudin Expressing Cancer Diseases
- Publication number 20240228616
- Publication date Jul 11, 2024
- BIONTECH AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES USEFUL IN CANCER DIAGNOSIS
- Publication number 20240209079
- Publication date Jun 27, 2024
- Astellas Pharma Inc.
- Rita MITNACHT-KRAUS
- G01 - MEASURING TESTING
Information Patent Application
BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN6 OR CLAUDIN18.2...
- Publication number 20240158501
- Publication date May 16, 2024
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
- Publication number 20240117022
- Publication date Apr 11, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICACY OF...
- Publication number 20240110247
- Publication date Apr 4, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6
- Publication number 20240101703
- Publication date Mar 28, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)
- Publication number 20240092896
- Publication date Mar 21, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...
- Publication number 20240091312
- Publication date Mar 21, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20240084033
- Publication date Mar 14, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE
- Publication number 20240075165
- Publication date Mar 7, 2024
- BIONTECH SE
- Ugur Sahin
- B82 - NANO-TECHNOLOGY
Information Patent Application
DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS
- Publication number 20240059772
- Publication date Feb 22, 2024
- BIONTECH AG
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Application
RNA COMPOSITIONS TARGETING CLAUDIN-18.2
- Publication number 20240043527
- Publication date Feb 8, 2024
- BIONTECH SE
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CORONAVIRUS VACCINE
- Publication number 20240002127
- Publication date Jan 4, 2024
- Pfizer Inc.
- Marjoh Nauta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES
- Publication number 20230303656
- Publication date Sep 28, 2023
- BIONTECH CELL & GENE THERAPIES GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2
- Publication number 20230270878
- Publication date Aug 31, 2023
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFICATION OF RNA, PRODUCING AN INCREASED TRANSCRIPT STABILITY AN...
- Publication number 20230193296
- Publication date Jun 22, 2023
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
- Publication number 20230193261
- Publication date Jun 22, 2023
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CORONAVIRUS VACCINE
- Publication number 20230073461
- Publication date Mar 9, 2023
- BIONTECH SE
- Ugur Sahin
- B82 - NANO-TECHNOLOGY
Information Patent Application
CORONAVIRUS VACCINE
- Publication number 20230075979
- Publication date Mar 9, 2023
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES
- Publication number 20220306711
- Publication date Sep 29, 2022
- BIONTECH CELL & GENE THERAPIES GMBH
- Ugur SAHIN
- G01 - MEASURING TESTING
Information Patent Application
ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES
- Publication number 20220288180
- Publication date Sep 15, 2022
- BIONTECH CELL & GENE THERAPIES GMBH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNA CONSTRUCTS AND USES THEREOF
- Publication number 20220273820
- Publication date Sep 1, 2022
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT VACCINES AND USE THEREOF
- Publication number 20220257783
- Publication date Aug 18, 2022
- BIONTECH SE
- Ozlem Tureci
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RNA CONSTRUCTS AND USES THEREOF
- Publication number 20220249704
- Publication date Aug 11, 2022
- BIONTECH SE
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF...
- Publication number 20220184209
- Publication date Jun 16, 2022
- Astellas Pharma Inc.
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES USEFUL IN CANCER DIAGNOSIS
- Publication number 20220162302
- Publication date May 26, 2022
- Astellas Pharma Inc.
- Rita MITNACHT-KRAUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICACY OF...
- Publication number 20210324472
- Publication date Oct 21, 2021
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Özlem Türeci

Person

Patents Grantslast 30 patents

Methods and compositions for prediction of therapeutic efficacy of...

Coronavirus vaccine

Combination therapy involving antibodies against Claudin 18.2 for t...

Antibodies against claudin 18.2 useful in cancer diagnosis

Coronavirus vaccine

Antibodies useful in cancer diagnosis

Antibodies specific for claudin 6 (CLDN6)

Antibodies for treatment of cancer expressing claudin 6

Combination therapy involving antibodies against claudin 18.2 for t...

Diagnosis and therapy of cancer involving cancer stem cells

Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2...

Monoclonal antibodies against Claudin-18 for treatment of cancer

Methods and compositions for prediction of therapeutic efficacy of...

Claudin-18.2-specific immunoreceptors and T cell epitopes

Coronavirus vaccine

Drug conjugates comprising antibodies against claudin 18.2

Methods and compositions for diagnosis and treatment of cancer

Therapy involving antibodies against Claudin 18.2 for treatment of...

Claudin-6-specific immunoreceptors and t cell epitopes

Antigen-specific T cell receptors and T cell epitopes

Recombinant vaccines and use thereof

Antibodies useful in cancer diagnosis

Combination therapy involving antibodies against claudin 18.2 for t...

Methods and compositions for prediction of therapeutic efficacy of...

Antibodies for treatment of cancer expressing claudin 6

Cancer therapy using CLDN6 target-directed antibodies in vivo

Combination therapy involving antibodies against Claudin 18.2 for t...

Antibodies specific for claudin 6 (CLDN6)

Monoclonal antibodies against claudin-18 for treatment of cancer

Identification of surface associated antigen FLJ31461 for tumor dia...

Patents Applicationslast 30 patents

CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELLS FOR THE TREATMENT OF CLDN6...

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...

ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS

Agents for Treatment of Claudin Expressing Cancer Diseases

ANTIBODIES USEFUL IN CANCER DIAGNOSIS

BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN6 OR CLAUDIN18.2...

MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER

METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICACY OF...

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

CORONAVIRUS VACCINE

DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

RNA COMPOSITIONS TARGETING CLAUDIN-18.2

CORONAVIRUS VACCINE

CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES

DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2

MODIFICATION OF RNA, PRODUCING AN INCREASED TRANSCRIPT STABILITY AN...

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

CORONAVIRUS VACCINE

CORONAVIRUS VACCINE

CLAUDIN-6-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES

ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES

RNA CONSTRUCTS AND USES THEREOF

RECOMBINANT VACCINES AND USE THEREOF

RNA CONSTRUCTS AND USES THEREOF

THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF...

ANTIBODIES USEFUL IN CANCER DIAGNOSIS

METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICACY OF...